Clinical Practice Guidelines on Adult Vaccination in Singapore
The Clinical Practice Guidelines on Adult Vaccination in Singapore aim to guide medical practitioners in screening adults for their vaccination requirements, as well as recommending the safe and effective administration of appropriate vaccines of adults.
These guidelines are meant only to guide clinical practice, and are not intended to replace medical judgement when managing adult individuals.
Please click here to view the guidelines.
Erratum:
It has been brought to our attention that the information on Medisave use for adult vaccination is incorrect in our Adult Vaccination Guideline.
The following table summarises the correction.
Table: Vaccines with incorrect Medisave use information and corrections
|
Page |
Vaccine(s) |
Incorrect information on Medisave use in current guideline |
Correct Information |
|
28 |
Haemophilus influenzae Type B (Hib) |
Up to $400 per year per account |
Medisave not allowed |
|
38 |
Human Papillomavirus (HPV) |
$400 per year per account up to age 26 years |
$400 per year per account for female patients between the ages of 9 to 26 years |
|
49 |
Measles, Mumps, Rubella (MMR) |
Up to $400 per year per account |
Medisave not allowed for adults |
|
55 |
Pneumococcal (PCV13 only) |
Claimable ($400 per year per account) for persons with higher risk of developing influenza-related complications and severe pneumococcal disease, respectively |
Medisave not allowed for adults |
|
60 |
Poliomyelitis |
Up to $400 per year per account |
Medisave not allowed for adults |
|
70 |
Tdap |
Up to $400 per year per account |
Medisave not allowed for adults |
|
75 |
BCG |
Up to $400 per year per account |
Medisave not allowed for adults |
